Haftka will lead the joint venture`s European business development effort and
establish first international office
CAMBRIDGE, Mass.--(Business Wire)--
Metabolix, Inc. (NASDAQ: MBLX) and Archer Daniels Midland Company today
announced the appointment of Stan Haftka, Ph.D., as Director of Business
Development, Europe, for Telles, the joint venture that is commercializing Mirel
bioplastics. Dr. Haftka will lead European business development with the opening
of Telles` first international office at ADM`s Europoort facility in the
Netherlands.
Dr. Haftka has 20 years of experience in the global specialty polymer market and
brings leadership assets important for the organization`s international growth.
"We`re pleased to have Stan join the Telles team as he will play an instrumental
role in the global expansion of our business," said Bob Engle, General Manager
of Telles. "His technical background, management and leadership experience, as
well as his prior success in leading European and Asian business development for
specialty polymers businesses will greatly benefit Telles."
Dr. Haftka joins Telles from the engineering polymers business of Celanese
Corporation, where he served as Global Segment Manager, GUR New Technologies,
responsible for managing the business segment globally. He successfully
developed and implemented new business strategies, managed numerous product and
application platforms, and received patents for new polymer applications.
About Mirel Bioplastics
Mirel is a family of bioplastic materials with the physical properties of
petroleum-based resins, yet with a unique combination of being biobased and
biodegradable in natural soil and water environments, and in home and industrial
composting facilities, in areas where such facilities are available. The rate
and extent of Mirel`s biodegradability will depend on the size and shape of the
articles made from it. However, like nearly all bioplastics and organic matter,
Mirel is not designed to biodegrade in conventional landfills.
Mirel bioplastics are available for injection molding, blown and cast film, and
cast sheet applications. Telles is the joint venture between Metabolix and
Archer Daniels Midland Company that is commercializing Mirel bioplastics. The
first commercial-scale plant to produce Mirel bioplastic resins is being
constructed adjacent to ADM's wet corn mill in Clinton, Iowa. For more
information please visit www.mirelplastics.com.
About Metabolix
Founded in 1992, Metabolix, Inc. is an innovation-driven bioscience company
focused on providing sustainable solutions for the world`s needs for plastics,
chemicals and energy. The Company is taking a systems approach, from gene to end
product, integrating sophisticated biotechnology with advanced industrial
practice. Metabolix is now developing and commercializing Mirel, a family of
high performance bioplastics which are biobased and biodegradable alternatives
to many petroleum based plastics. Metabolix is also developing a proprietary
platform technology for co-producing plastics, chemicals and energy, from crops
such as switchgrass, oilseeds and sugarcane.
For more information, please visit www.metabolix.com. (MBLX-G)
ICR
Media:
Matt Lindberg, 203-682-8214
matthew.lindberg@icrinc.com
or
Brian Ruby, 203-682-8268
brian.ruby@icrinc.com
or
Investors:
James Palczynski, 203-682-8229
james.palczynski@icrinc.com
Copyright Business Wire 2009
